// App-Quantinova.ai

5559 : Where have we gone wrong? Phase 2 trials (Ph2t) do not inform the results of Phase 3 trials (Ph3t) in platinum resistant ovarian cancer (PROC).

Researchers

Presenter

  • Tami Grunewald

Principal Investigators

  • Monica Tang

  • Julia Chen

  • Sally Lord

  • Michael Friedlander

  • Chee Khoon Lee

Medical Centers

  • Prince of Wales Hospital, Randwick, Australia

  • St George Hospital, Sydney, Australia

  • NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • Prince of Wales Hospital, Randwick, Australia

  • St George Hospital, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved